© 2019 Bruder Consulting & Venture Group, All Rights Reserved.  New York, United States

Please reload

Recent Posts

Dr. Scott Bruder to Lecture on Selection of Appropriate Clinical Targets for Regenerative Medicine at the 4th Annual Mid-Atlantic Advanced Biomanufact...

August 30, 2019

1/3
Please reload

Featured Posts

Histogenics Completes Enrollment for Phase 3 Clinical Trial of Neocart® to Treat Knee Cartilage Damage

June 27, 2017

 

Click here of the full article.

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags